MX2011008323A - Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. - Google Patents

Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.

Info

Publication number
MX2011008323A
MX2011008323A MX2011008323A MX2011008323A MX2011008323A MX 2011008323 A MX2011008323 A MX 2011008323A MX 2011008323 A MX2011008323 A MX 2011008323A MX 2011008323 A MX2011008323 A MX 2011008323A MX 2011008323 A MX2011008323 A MX 2011008323A
Authority
MX
Mexico
Prior art keywords
renal
prognosis
diagnosis
compositions
methods
Prior art date
Application number
MX2011008323A
Other languages
English (en)
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of MX2011008323A publication Critical patent/MX2011008323A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Abstract

La presente invención es concerniente con métodos y composiciones para el monitoreo, diagnosis, prognosis y determinación de regímenes de tratamiento en sujetos que sufren de o se sospecha que tienen lesión renal. En particular, la invención es concerniente con el uso de análisis que detectan uno o más marcadores seleccionados del grupo que consiste de fosfatasa de ácido prostático, lactotransferrina, receptor de eritropoyetina soluble, factor de Von Willebrand, receptor C de proteína endotelial soluble y beta-2-glicoproteína 1 como biomarcadores de diagnóstico y prognóstico en lesiones renales.
MX2011008323A 2009-02-06 2010-02-05 Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal. MX2011008323A (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US15039309P 2009-02-06 2009-02-06
US15037209P 2009-02-06 2009-02-06
US15037409P 2009-02-06 2009-02-06
US16239609P 2009-03-23 2009-03-23
US16240209P 2009-03-23 2009-03-23
US16633309P 2009-04-03 2009-04-03
PCT/US2010/023292 WO2010091231A1 (en) 2009-02-06 2010-02-05 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
MX2011008323A true MX2011008323A (es) 2011-09-21

Family

ID=42542388

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011008323A MX2011008323A (es) 2009-02-06 2010-02-05 Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.

Country Status (11)

Country Link
US (1) US20160123996A1 (es)
EP (1) EP2393937A4 (es)
JP (3) JP2012517592A (es)
CN (3) CN102369293B (es)
AU (1) AU2010210535B2 (es)
BR (1) BRPI1007917A2 (es)
CA (1) CA2751424A1 (es)
HK (2) HK1162617A1 (es)
MX (1) MX2011008323A (es)
NZ (1) NZ630621A (es)
WO (1) WO2010091231A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010025434A1 (en) * 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
AU2010267972A1 (en) * 2009-07-02 2012-01-19 Mosaiques Diagnostics And Therapeutics Ag Method and markers for diagnosing acute renal failure
CN106248921A (zh) * 2010-09-24 2016-12-21 阿斯图特医药公司 利用透明质酸评价肾损伤的方法和组合物
EP2882767B1 (en) * 2012-08-11 2023-07-12 Astute Medical, Inc. Evaluating renal injury using hyaluronic acid
EP2951581A4 (en) * 2013-01-29 2016-07-20 Astute Medical Inc METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
WO2015084939A1 (en) * 2013-12-03 2015-06-11 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CL2015003047A1 (es) * 2015-10-15 2016-06-17 Univ Chile Método ex vivo para detectar precozmente injuria renal aguda en pacientes críticos, que comprende la mediciom en una muestra de tres proteinas como biomarcadores, factor de crecimiento fibroblástico 23, klotho y eritropoyetina
CN105466984B (zh) * 2016-01-14 2018-12-28 郑以山 用于肾脏非显性损伤的预警装置及其使用方法
WO2017130985A1 (ja) * 2016-01-29 2017-08-03 株式会社国際電気通信基礎技術研究所 腎機能の評価装置、腎疾患の合併症の発症の予測装置、およびリン摂取量推定装置
CN106845140A (zh) * 2017-03-01 2017-06-13 重庆工商大学 一种基于尿比重和尿量监测的肾衰竭预警方法及系统
MX2019014441A (es) * 2017-05-30 2020-02-10 Sphingotec Gmbh Un metodo in vitro para diagnosticar o monitorear la funcion renal o diagnosticar disfuncion renal.
CN109897108B (zh) * 2019-03-11 2021-04-02 上海恒赛生物科技有限公司 抗人内皮蛋白c受体的羊驼单域抗体及应用
EP3881862A1 (de) * 2020-03-18 2021-09-22 Pharis Biotec GmbH Polypeptid zur therapie von glomerulären nierenerkrankungen und analyse des verlaufes und prognose der abhängigen syndrome

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3569577B2 (ja) * 1995-09-04 2004-09-22 株式会社いかがく 腎・尿路系疾患の鑑別診断用キット
US6498142B1 (en) * 1996-05-06 2002-12-24 Curis, Inc. Morphogen treatment for chronic renal failure
US6228360B1 (en) * 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
JP2003030100A (ja) * 2001-07-12 2003-01-31 Fuji Xerox Co Ltd インターネット情報提供システムおよびインターネット情報提供方法
ES2268961B1 (es) * 2005-03-17 2008-03-16 Proyecto De Biomedicina Cima, S.L. Nueva proteina epcr soluble de origen no proteolitico y su uso.
CA2614935A1 (en) * 2005-07-21 2007-02-01 The Johns Hopkins University Methods of detecting and treating acute kidney injury
TW200726845A (en) * 2006-01-02 2007-07-16 Nat Defense Medical Ct Biomarker molecular of renal illness and detecting method for the same
US7662578B2 (en) * 2006-04-21 2010-02-16 Children's Hospital Medical Center Method and kit for the early detection of impaired renal status
US20080038269A1 (en) * 2006-05-25 2008-02-14 Mount Sinai Hospital Methods for detecting and treating kidney disease
GB0617429D0 (en) * 2006-09-05 2006-10-18 Electrophoretics Ltd Markers of renal transplant rejection and renal damage
WO2008060607A2 (en) * 2006-11-14 2008-05-22 Biosite Incorporated Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
EP2160478B1 (en) * 2007-06-06 2014-08-27 Siemens Healthcare Diagnostics Inc. Predictive diagnostics for kidney disease

Also Published As

Publication number Publication date
CN104111336B (zh) 2017-01-18
WO2010091231A1 (en) 2010-08-12
CN102369293B (zh) 2014-05-28
HK1162617A1 (en) 2012-08-31
AU2010210535A1 (en) 2011-09-15
HK1200218A1 (en) 2015-07-31
US20160123996A1 (en) 2016-05-05
JP2015096870A (ja) 2015-05-21
BRPI1007917A2 (pt) 2019-09-24
EP2393937A4 (en) 2012-08-08
JP2012517592A (ja) 2012-08-02
CN106546752A (zh) 2017-03-29
NZ630621A (en) 2016-03-31
JP2016194526A (ja) 2016-11-17
CN102369293A (zh) 2012-03-07
CA2751424A1 (en) 2010-08-12
EP2393937A1 (en) 2011-12-14
CN104111336A (zh) 2014-10-22
AU2010210535B2 (en) 2015-12-10

Similar Documents

Publication Publication Date Title
MX2011008323A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
EP3070474A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX341191B (es) Metodos y composiciones para diagnostico y prognosis de lesion renal y falla renal.
EP2767833A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ619883A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX346096B (es) Métodos y composiciones para diagnóstico y pronóstico de lesión renal e insuficiencia renal.
EP2585827A4 (en) METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency
MX2011002233A (es) Metodos y composiciones para la diagnosis y prognosis de daño renal y falla renal.
NZ625423A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
MX336280B (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
MX350533B (es) Biomarcadores de cancer pancreatico y usos de los mismos.
NZ620799A (en) Molecular diagnostic test for cancer
NZ592488A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008061149A3 (en) Methods and compositions for diagnosis and prognosis of renal artery stenosis
WO2011035012A3 (en) Methods and compositions for diagnosing heart failure
WO2011015944A3 (en) Use of free dna as an early predictor of severity in acute pancreatitis
WO2008128043A3 (en) Diagnostic and prognostic methods for renal cell carcinoma
WO2012094658A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2009101059A3 (en) Methods of using cadherin 11 (cdh11) antagonists
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2585826A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE
EA201490105A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
MX2012003168A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal e insuficiencia renal.
MX339765B (es) Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal.

Legal Events

Date Code Title Description
FG Grant or registration